Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc.
Ryan Allway May 27th, 2022 Psychedelics, Top News Halucenex to receive recently harvested first batch of psilocybe cubensis May 27, 2022 VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational human... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )